Similarly, we identified 57 potential TSGs, of which at least 13 have been implicated in cancer, including HOXB13, ZNF350, ZNF331, CNTNAP2, NEFH, and ABR with reduced expression due to hypermethylation or loss. The gene discussed is NEFH; the disease is cancer.